
Dr. Andrey Kruglov
Programme Area 3, PA 3 – Systems Rheumatology
Group leader: Chronic Inflammation
Scientific Background
Since 2016rnGroup Leader at DRFZ, Berlin, Germanyrnrn2013-2022rnLeading Staff Scientist at A.N. Belozersky Institute of Physico-chemical Biology, M.V. Lomonosov Moscow State University, Moscow, Russiarnrn2015-2016rnGuest Scientist at DRFZ, Berlin, Germanyrnrn2009-2015rnPostdoctoral Scientist at DRFZ, Berlin, Germany
2004-2009rnPhD in Biology, Engelhardt Insitute of Molecular Biology, Moscow, Russiarnrn1999-2004rnMaster of Science in Chemistry, Chemistry Department, M.V. Lomonosov Moscow State University, Msocow, Russia
Since 2022rnOrganisation of B cell seminar at DRFZrnrn2022-2024rnAd-hoc reviewer for Gut Microbes, Gastroenterology, cellular immunology and etc.rnrn2022-2024rnReviewer of grant proposal for CNRS and SNSF
Since 2012rnMember of German Society of Immunology (DGFI)
2021rnLeibniz Research Alliance Bioactive Compounds and Biotechnology: “Identification of protein structures resembling RBD of SARS-CoV-2 by human commensal microrganisms” PI: Andrey Kruglov and Co-PI: Jorg Overmann.
TOP 5 PUBLICATIONS
Kruglov lab
